Data for: Dual antibody induction and de novo use of everolimus enable low-dose tacrolimus with early corticosteroid withdrawal in simultaneous pancreas-kidney transplantation

Name: Data for: Dual antibody induction and de novo use of everolimus enable low-dose tacrolimus with early corticosteroid withdrawal in simultaneous pancreas-kidney transplantation
Creator: Jun Li
Published: 2018-06-08T11:44:19.057Z
Keywords: Immunosuppression, Pancreas Transplantation

Li, Jun; Kloth, Katja; Kramer, Kathrin; Scheidat, Silke; Achilles, Eike; Rinninger, Franz; Fischer, Lutz; Abu Ganim, And el Rahman; Koch, Martina; Gulati, Amit; Nashan, Björn; Thaiss, Friedrich; Herden, Uta

doi:10.17632/pnz6vss2bv.1

Data for: Dual antibody induction and de novo use of everolimus enable low-dose tacrolimus with early corticosteroid withdrawal in simultaneous pancreas-kidney transplantation

Published: 8 June 2018| Version 1 | DOI: 10.17632/pnz6vss2bv.1

Contributors:

Jun Li, Katja Kloth, Kathrin Kramer, Silke Scheidat, Eike Achilles, Franz Rinninger, Lutz Fischer, And el Rahman Abu Ganim, Martina Koch, Amit Gulati, Björn Nashan, Friedrich Thaiss, Uta Herden

Description

Here are the put to 5-year follow-up data

Data for: Dual antibody induction and de novo use of everolimus enable low-dose tacrolimus with early corticosteroid withdrawal in simultaneous pancreas-kidney transplantation

Description

Files

Categories

Licence